Figure 2 - uploaded by Nelson R. Pinto
Content may be subject to copyright.
Macroscopic evaluation of the PRF clots produced with the 4 different centrifuges: original Intra-Spin L-PRF system (A) , A-PRF system (B) , Salvin centrifuge (C) and LW centrifuge (D) . Obvious differences can be observed in terms of size and aspect, the original L-PRF (A) being always denser and heavier (and in most cases larger) than the others.
Source publication
Background and Objectives. Platelet concentrates for surgical use (Platelet-Rich Plasma PRP or Platelet-rich fibrin PRF) are surgical adjuvants to improve healing and promote tissue regeneration. L-PRF (Leukocyte-and Platelet-Rich Fibrin) is one of the 4 families of platelet concentrates for surgical use and is widely used in oral and maxillofacial...
Context in source publication
Context 1
... and cell and growth factors contents of the L-PRF are key characteristics of an original L-PRF clot/membrane as characterized in the literature [19] , and any modification of the material and protocol can lead to a different biological signature and clinical result [18] . The objective of this series of 3 articles was to point out the impact of the centrifuge characteristics and centrifugation protocol on the cell, growth factors and fibrin architecture of a L-PRF clot and membrane. In the first article, the mechanical vibrations (both radial and vertical) appearing during centrifugation were evaluated in 4 models of commercially available table centrifuges frequently used to produce L-PRF. It was proven that the original L-PRF centrifuge (Intra-Spin) was by far the most stable machine. At the classical speed of production of L-PRF, the level of undesirable vibration on this centrifuge is between 4.5 and 6 times lower than with other centrifuges. Moreover, Intra-Spin always remains under the threshold of resonance, unlike the 3 other tested machines. In this second article, the exact macroscopic and microscopic (photonic and scanning electron microscopy) characteristics and the cell composition of the L-PRF clots and membranes produced with these 4 different machines were evaluated. As a secondary objective, the impact of the vibration parameter on the architecture and cell content of the L-PRF clots was discussed. The study was conducted in accordance with the Helsinki Declaration (2000) and approved by the Medical Ethics Committee of the University of the Andes (UANDES). All volunteers provided signed informed consent. In this study, 4 different centrifuges, found on the market and used to produce L- PRF, were tested. The country of manufacture being used by some companies as a claim for quality, the country of manufacture of each centrifuge and its main components was checked. The 4 selected centrifuges were purchased from their manufacturers (or distributors). The first centrifuge was the original centrifuge used during the early development of the L-PRF open-access method and is nowadays marketed under the name Intra-Spin L-PRF centrifuge (Intra-Lock International, Boca-Raton, FL, USA; Made in Germany). It is actually the only CE marked and FDA cleared system for the preparation of L-PRF clots. The 3 other centrifuges are not CE/FDA cleared for L-PRF, but they can be found relatively frequently available on the market for this use (mostly because they are much cheaper): centrifuge A-PRF 12 (Advanced PRF, Process for PRF, Nice, France; Country of manufacture not indicated on the label, components inside show “Made in China”), centrifuge LW - UPD8 (LW Scientific, Lawrenceville, GA, USA; Components made in China, assembled in the USA) and centrifuge Salvin 1310 (Salvin Dental Specialties, Charlotte, NC, USA; Made in China). Blood samples were collected at the San Bernardo University of the Andes Health Center from 8 healthy volunteers (age range 25-35 years, ASA 1), with no history of recent aspirin intake or any medication neither disease correlated with the coagulation process. For each volunteer, nine tubes of blood were obtained from the antecubital vein. One tube with 2,5ml of anticoagulant was used for whole blood analysis as a control for normal blood parameters. Eight plastic glass-coated tubes were taken without anticoagulant (with BD Vacutainer Serum 10.0ml tubes, Becton Dickinson, Franklin Lakes, NJ, USA) for the production of L-PRF clots and membranes. The blood was collected quickly (22 seconds mean value, less 25 seconds per tube) and immediately (before 1 minute) centrifuged at 400g during 12 minutes in the four different centrifuges (two tubes were distributed per centrifuge in a randomized way) at room temperature. To standardize exactly the protocol and isolate only the centrifuge vibration parameter, the 400g centrifugation force used in the original L-PRF method (corresponding to 2700 rpm in the original Intra-Spin centrifuge) was used with all centrifuges, and rpm were adjusted accordingly for each centrifuge, i.e. 2400 rpm for the A-PRF machine and 2300 rpm for the LW centrifuge. Salvin centrifuge has only one preset possible speed (3400 rpm), which lead to a centrifugation force higher than 400g. The temperatures of the surface at the center of the tubes were registered before and after centrifugation with an infrared thermometer (HVACPro, Fluke, Everett, WA, USA). A total of 64 L-PRF clots/membranes were obtained: 32 membranes were prepared for Scanning Electron Microscopy (SEM) analysis and 32 membranes were prepared for light/photonic microscopy. After centrifugation the L-PRF clot was removed from the tube using sterile tweezers and a smooth spatula to gently release the red blood cells clot inside the tube ( Figure 1A ). The L-PRF fibrin clot obtained was placed on a sterile microscope slide ( Figures 1B, 1C ) placed in an individual tray for weight and size measurements ( Figure 2 ). The supernatant and red blood cells clot remaining in the tube were also weighted to get the L-PRF fibrin clot / whole blood ratio per tube. Each sterile microscope slide had in every corner a 1mm rubber stop ( Figure 1C) to allow the compression of the clot with another microscope slide using 100 grams constant pressure for two minutes. This standardized method allowed to obtain from each clot 1mm-thick L-PRF membranes, which were weighted and measured individually ( Figure 3 ). From each volunteer, two membranes were obtained per each centrifuge and after macro analysis (weight, size measurements) were prepared for histologic procedures. One membrane was prepared for SEM evaluation and the second one for light-microscopy analysis. The membranes were kept between the microscope slides during fixation to avoid distortions. The membranes were fixed in 10% neutrally buffered formalin for 24 hours at room temperature for paraffin inclusion. Successive sections of 4 microns were performed along the center of the long axis of the membranes and were stained with hematoxylin-eosin. Each section was divided in three areas of equal size: Proximal (Head & Face), Center (Body), Distal (Tail). Each area of these sections was observed through light microscopy and analyzed by counting the visible cell bodies (marked in dark purple, mostly leukocytes) in the center of each area observed with a 40X magnification. The total numbers of counted cell bodies were used to correlate their distribution among the three areas of the membrane (head & face, body and tail). Most of the cells were concentrated in the proximal area (head & face). A morphologic evaluation of the L-PRF membranes was done with a scanning electron microscope. The membranes were fixed in 2.5% glutaraldehyde for 24 hours at 4oC and treated for gradual desiccation. The specimens were sputter-coated with 20nm gold (Edwards S-150, Crawley, UK) and examined in a scanning electron microscope (JEOL JSM- 6380LV, JEOL Ltd, Tokyo, Japan). Photographs were taken with 15 to 20kV using 2,000 to 5,000X magnifications. This study was mainly descriptive. All the macroscopic results are presented in the Table . The numeric values are clearly illustrated by the observation of the clots and membranes in the Figures 2 and 3 . For the temperature of the tubes, Intra-Spin allowed to keep the lowest temperature among the 4 tested machines. A-PRF and Salvin were both associated with a significant increase of temperature in the tube. For the clot and exudate weights, Intra-Spin produced by far the heaviest clot and quantity of exudate among the 4 techniques. Salvin remains high but far behind. Finally A- PRF and LW produced very light and small clots. For the membranes weights, Intra-Spin and Salvin presented similar weight. The A-PRF and LW membranes were significantly lighter. In terms of clot and membrane length and width, the clots and membranes from Intra-Spin and Salvin presented similar sizes. The A-PRF and LW clots and membranes were significantly shorter and more narrow. Finally, the Intra-Spin L-PRF clot was the heaviest clot to be produced with an initial blood harvest of ...
Similar publications
Platelet-rich fibrin (PRF), developed in France by Choukroun et al (2001), is a second generation platelet concentrate widely used to
accelerate soft and hard tissue healing. Its advantages over the better known platelet-rich plasma (PRP) include ease of
separation/application, minimal expense, and lack of biochemical modification (no bovine throm...
Citations
... Moreover, this blood-derived membrane is enriched with leukocytes, which play a key role not only in immune and antibacterial responses, but also in the wound healing process [7,8]. Since Choukroun's PRF was first described, many variations of the original protocol have appeared, resulting in the production of PRF-like materials with different architectures and cell contents [9][10][11][12][13][14][15][16][17]. The fundamental challenge to be overcome remains the concentration of platelets, which should be increased to a minimum of 5 times above baseline values for the hemocomponent to be considered "platelet rich" [18]. ...
Nowadays, research in Tissue Engineering and Regenerative Medicine is focusing on the identification of instructive scaffolds to address the requirements of both clinicians and patients to achieve prompt and adequate healing in case of injury. Among biomaterials, hemocomponents, and in particular Platelet-rich Fibrin matrices, have aroused widespread interest, acting as delivery platforms for growth factors, cytokines and immune/stem-like cells for immunomodulation; their autologous origin and ready availability are also noteworthy aspects, as safety- and cost-related factors and practical aspects make it possible to shorten surgical interventions. In fact, several authors have focused on the use of Platelet-rich Fibrin in cartilage and tendon tissue engineering, reporting an increasing number of in vitro, pre-clinical and clinical studies. This narrative review attempts to compare the relevant advances in the field, with particular reference being made to the regenerative role of platelet-derived growth factors, as well as the main pre-clinical and clinical research on Platelet-rich Fibrin in chondrogenesis and tenogenesis, thereby providing a basis for critical revision of the topic.
... It was not possible to directly quantify the platelet concentration and WBC trapped inside the L-PRF clot, which was derived indirectly by comparing the mean values of whole blood, the mean values of the supernatant obtained after compression of the clot at 2 min, and the average values obtained counting the smears of the red clot after the removal of the L-PRF clot. Table 1 compares the characteristics of clots and membranes of L-PRF obtained in humans (centrifugal Intraspin) reported by Pinto et al. [12] and Dohan Ehrenfest et al. [13,14] and those we observed in the horse model. In this comparison, it was verified that there are significant differences in the characteristics of the clot, but these differences are eliminated when the membranes derived from the compression were examined. ...
... Fibrin, platelets, growth factors, leukocytes, and other cells play a major role in natural healing; therefore, to promote surgical site healing, all these components are combined in modern platelet-rich preparations. 6 The current classification of platelet-rich concentrates is based on their fibrin architecture and cell content. It consists of two main groups of products, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), both of which are available in a pure or leukocyte-enriched form (L-PRP and L-PRF). ...
... Multiple surgical specialties have recognized the potential benefits of platelet-rich concentrates. Their use has been described in ophthalmology, neurosurgery, general surgery, 7 orthopedic surgery, sports medicine, 6 and oral and maxillofacial surgery. 1,8 Several applications of L-PRF concentrate have been described in the literature including postoperative hand wound healing yielding faster reepithelization and in the treatment of androgenic alopecia diminishing hair loss among others. ...
Objective Advancements in endoscopic endonasal approaches have increased the extent and complexity of skull base resections, in turn demanding the development of novel techniques for skull base defect reconstruction. The objective of this pilot study was to investigate the effect of leukocyte–platelet-rich fibrin (L-PRF) on the postoperative healing after endoscopic skull base surgery.
Methods Between January and May of 2015, 47 patients underwent endoscopic endonasal resection of sellar, parasellar, and suprasellar lesions with the application of L-PRF membranes during the skull base reconstruction at two surgical centers. Early postoperative records were retrospectively reviewed.
Results We found that 21 days following the surgery, 17/41 patients (42%) demonstrated improvement in the crusting score as compared with their 7 day postoperative examination. Ten of these patients (23%) showed no crusting. Fourteen (34%) patients had no change in the crusting score. Six patient records were incomplete. A total of 4/47 cases (8.5%) had postoperative cerebrospinal fluid leak requiring surgical repair.
Conclusion This study demonstrates the potential utility of L-PRF membranes for skull base defect reconstruction. Future studies will be conducted to better assess the role of L-PRF in endoscopic skull base surgery.
... Fibrin, platelets, growth factors, leukocytes, and other cells play a major role in natural healing; therefore, to promote surgical site healing, all these components are combined in modern platelet-rich preparations. 6 The current classification of platelet-rich concentrates is based on their fibrin architecture and cell content. It consists of two main groups of products, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), both of which are available in a pure or leukocyte-enriched form (L-PRP and L-PRF). ...
... Multiple surgical specialties have recognized the potential benefits of platelet-rich concentrates. Their use has been described in ophthalmology, neurosurgery, general surgery, 7 orthopedic surgery, sports medicine, 6 and oral and maxillofacial surgery. 1,8 Several applications of L-PRF concentrate have been described in the literature including postoperative hand wound healing yielding faster reepithelization and in the treatment of androgenic alopecia diminishing hair loss among others. ...
Objective: Autologous platelet rich preparations and fibrin glue technologies have been used for many years to promote surgical site healing. Recent advancements in the endoscopic endonasal approach and a significant increase in the extent of the skull base defects demand more elaborate reconstruction and novel techniques to expedite healing and prevent post-operative reconstruction failures. The objective of this pilot study was to investigate the effect of leukocyte platelet rich fibrin (L-PRF) on the post-operative recovery and the rate of complications in the endoscopic endonasal skull base surgery. Methods: Between January and May of 2015, a total of 47 patients, 22 males and 25 females with mean age of 51, underwent endoscopic endonasal approach (EEA) resection of various pituitary and suprasellar masses with L-PRF membrane application during the skull base defect reconstruction. Following IRB approval, their post-op follow up records were retrospectively reviewed to evaluate the rate of CSF leaks and post-surgical healing. The crusting scale score was used as an indicator of healing progression. The healing was assessed during routine follow up with the following scale values assigned based on sinonasal endoscopy: 0-no crusting; 1-minimal crusting debrided with suction only; 2-moderate crusting requiring forceps debridement; 3-severe crusting causing obstruction. The crusting scale values were compared between 7-day and 21-day follow up. Results: The EEA resections included in this pilot study were performed for several sellar and suprasellar lesions, with pituitary adenoma (Hardy score I-IVE) being the most common lesion. The surgery itself varied in extent involving transsphenoidal, transplanal, transclival, transcribiform, transethmoidal or transpterygoid approaches depending on the extent of the lesion. A total of 4/47 cases (8.5%) had post-operative CSF leak requiring surgical repair. One of the cases had recurrent CSF leaks with multiple repairs indicating multifactorial etiology for reconstruction failure. The crusting score assessment revealed that 17/41 (42%) patients had crusting score improvement, while 14/41 (34%) patients had no change in the crusting score 21 days post-op as compared with 7 day post-op visit. Ten patients (10/41, 31%) had no crusting on 21-day post-op exam. Only 10/41 (24%) patients had a higher crusting score during their 21-day post-op follow up. Six patient records did not have complete crusting scale information. Discussion: This study demonstrates the potential utility of L-PRF membranes for skull base defect reconstruction with encouraging rate of healing progression after perioperative L-PRF application to the surgical site. The CSF leak rate of 8.5% found during this study is similar to the overall CSF leak rate quoted in the literature for all reconstructive techniques. The investigators expect that with a larger sample size, the rate of post-operative CSF leak with L-PRF membrane application during reconstruction will be lower. Future studies with a larger sample size and a multivariate analysis of variables that affect post-surgical healing will be conducted to better assess the role of L-PRF in the skull base defect reconstruction.
... None of the three centrifuges used in this study had a built-in cooling system. In the PRF clots produced and for three centrifuge groups, visual inspection of clots came in agreement with previous studies with a standard bulky PRF clot being comprised of three portions (serum fraction, bulky yellow colored fibrin portion and a bottom red blood cell layer (9,13,35) . In regard to clot dimensions in the current study, a highly significant difference was disclosed in terms of clot length with group Hettich being longest but no significant difference in terms of width ( 35.30mm * 13.32mm) , group 800-D (30.59mm * 12.47) and group 80-2 (27.15 * 12.52). ...
Aims: The aims of the current study were to show the differences between original Platelet-Rich Fibrin (PRF) clots produced by a specifically designed centrifuge for this purpose and those clots produced by other centrifuges in terms of clot temperature and clot dimensions. Materials and Methods: The study included five human volunteers. From each volunteer, six 9 ml blood samples were collected (Total number= 30) and immediately centrifuged, each ten blood samples allocated to a centrifuge group (total of three), one of which was the original recommended centrifuge (Hettich). The three produced clot were assessed and compared in terms of visual inspection and clot dimensions using a computer software program. Results: For clot dimensions, a significant difference was observed between clots in terms of length but no significant difference in terms of clot width. Conclusions: Differences in clot dimensions are due to the centrifuge characteristics, namely heat generation and vibrations. Within the limitations of the current study, any Platelet Rich Fibrin clot produced without respecting the original protocol should be termed Leucocyte Platelet-Rich Fibrin-like product and this term is preferred to be added to the recent global classification.
... The first histological description of a PRF membrane was conducted by Dohan Ehrenfest et al. (29) followed by Pinto et al.. (30) . The protocol for histological processing in their study for membranes were followed in the current study (except exact membrane thickness which was difficult to control). ...
Aims: The aims of the current study were to show the differences and similarities between original Platelet-Rich Fibrin (PRF) clots produced by a specifically designed centrifuge for this purpose and those clots produced by other centrifuges using bright light microscopy. Materials and Methods: The study included five human volunteers. From each volunteer, six 9 ml blood samples were collected (Total number= 30) and immediately centrifuged, each ten blood samples allocated to a centrifuge group (total of three), one of which was the original recommended centrifuge (Hettich). A set of six histological observations were made and considered as a histological scoring system for the purpose of comparison of different membranes. Results: Out of the six observations, only two showed a significant difference between the three membranes produced namely density of inner fibrin zone density and cell border morphology. Conclusions: Differences in clot membrane histological observations are due to the centrifuge characteristics, namely heat generation and vibrations. Within the limitations of the current study, any Platelet Rich Fibrin clot produced without respecting the original protocol should be termed Leucocyte Platelet-Rich Fibrin-like product and this term is preferred to be added to the recent global classification.
... The second issue of 2014 (Volume 2, Issue 2) was the first PACT issue of the POSEIDO Journal [4]. It reviewed the current endeavor in the field and gathered several major articles on the topic, particularly concerning the diversity of cells observable in a platelet concentrate and the impact of centrifuge quality and protocol on the cell content and biological signature of L-PRF (Leukocyte-and Platelet-Rich Fibrin) clots and membranes [5]. This issue is a good illustration of the PACT philosophy and a major scientific milestone prepared by this Community. ...
... 2014;2(3) The ISAIAS Prophecy in Higher Education and Research ISSN 2307-5295, Published by the POSEIDO Organization & Foundation under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) Licenseseveral Editors in Chief at the end of the global development. The first POSEIDO journal is not a mass-publication platform, it is mostly a journal focusing on major specific studies and trying to develop a international collaborative work, as it can be observed in the last issues about the characterization of implant surfaces[16,17] or the comparison of various centrifuges for platelet concentrates[18]. The first issues of early 2014[17,19] were downloaded already more than 15,000 times making this relatively small open-access journal one of the most downloaded (and hopefully read) in the profession. ...
Internationalization of Higher Education and Research is a major evolution of the Academic environment, and it is also impacting in a specific way the dental disciplines. It is originally a concept to promote cooperation and peace between cultures and Nations, through the development of an efficient intercultural Academic interface. This introductory article reviewed the origin, causes and consequences of this process in the global scientific cooperation, and discussed how the current models of internationalization have generated independent blocks around centers of influence. These centers are entering in a scheme of global competition for influence, far from the initial honest concept of cooperation. This article also introduces the paradigm of " intelligent internationalization " , as a flexible and versatile method to create and maintain an interface between institutions, cultures and countries. This model is the basis of the POSEIDO Consortium (Periodontology, Oral Surgery, Esthetic & Implant Dentistry Organization) and is founded on the concept of network of leaders of internationalization. To monitor and strengthen this effort, the POSEIDO Consortium is developing an Academic toolbox termed ISAIAS (Intercultural Sensitivity Academic Index & Advanced Standards), as an initiative to promote deeper cooperation and to develop long-term common efforts in Higher Education and Research.
Autologous platelet concentrates have been used in regenerative medicine in humans due to the abundance of growth factors, but there are only a few reports in small animals. This study aimed to prepare and characterize a leukocyte and platelet-rich fibrin membrane (L-PRF) produced with blood obtained from cats. Thirteen client-owned healthy adult Maine Coon cats were enrolled. The blood samples were collected and centrifuged at 650g for 12 min using a centrifuge specifically designed for this application. The L-PRF clot was removed from the tube and red blood cell base layer was separated, leaving buffy coat intact. After this, L-PRF clot was compressed by specialized metal plate for 30-60 s, and L-PRF membrane was obtained. Light microscopy examination of the membranes showed three distinct layers: white part, buffy coat, and red part. Immunohistochemical analysis demonstrated expression of vascular endothelial growth factor and platelet derived growth factor. The scanning electron microscopy showed that three-dimensional architecture of fibrin network was more compact in the area near the buffy coat. In conclusion, the method used allowed the characterization of the L-PRF membrane composition, which presented cell types and fibrin network architecture similar to those described in the human species.
Autologous platelet‐rich hemocomponents have emerged as potential biologic tools for regenerative purpose, but their therapeutic efficacy still remains controversial. This work represents the characterization study of an innovative autologous leukocyte‐fibrin‐platelet membrane (LFPm) which we prepared according to a novel protocol involving multiple cycles of apheresis. The high content in fibrinogen gave to our hemocomponent the appearance of a manipulable and suturable membrane with high elasticity and deformation capacity. Moreover, being highly enriched with platelets, leukocytes, monocytes/macrophages the LFPm sustained the local release of bioactive molecules (Platelet Derived Growth Factor, Vascular Endothelial Growth Factor, Interleukin‐10 and Tumor Necrosis Factor alpha). In parallel, the evaluation of stemness potential highlighted also that the LFPm contained cells expressing pluri‐ and multipotency markers both at the mRNA (NANOG, SOX2, THY1, NT5E and ENG) and surface‐protein level (CD44high/CD73+/CD34+/CD117+/CD31+). Finally, biodegradation analysis interestingly showed a good stability of the membrane for at least 3 weeks in vitro and 1 week in vivo. In both cases, biodegradation was associated with progressive exposure of fibrin scaffold, loss/migration of cellular elements and release of growth factors. Overall, collected evidence could shed some light on the regenerative effect that LFPms may exert after the autologous implant on a defect site.